The 2nd International Hereditary Cancers Congress

Published: 30 January 2026

Details:

Join us from 05–08 February 2026 in Antalya, Turkey, for the 2nd International Hereditary Cancers Congress. Organized by the Hereditary Cancer Association, this premier event unites global experts to bridge groundbreaking genetic research with real-world clinical practice.

As the conversation shifts from identifying genetic risk to active clinical application, Gene Solutions, in collaboration with ATC, invites you to an exclusive Satellite Symposium:​

“ctDNA across the Cancer Care Continuum – From Screening to Precision Care: Insights for High-Risk and Hereditary Populations”​

This session will explore the cutting edge of oncology, featuring:​

• Scalable Early Detection: Insights into AI-powered multi-omics for Multi-cancer Early Detection (MCED) and the clinical validation behind SPOT-MAS/KDETEK.​
• Comprehensive Surveillance: The clinical value of integrated genomic and transcriptomic profiling combined with longitudinal Molecular Residual Disease (MRD) monitoring (K4CARE) for personalized therapy guidance.​
• Real-World Integration: A deep dive into multi-omics ctDNA adoption, addressing evidence gaps and opportunities within Turkey and the global medical community.​

📍 Time: 11:30-12:15PM, 05–08 Feb 2026 ​

📍 Location: Rixos Premium Belek, Antalya, Turkey​

🔗 Explore the complete program here: https://vcard.okr.business/hereditarycancerscongress.org-eng-bilimsel-program.php ​​